You are currently viewing a new version of our website. To view the old version click .

Pharmaceutics, Volume 11, Issue 12

December 2019 - 70 articles

Cover Story: A C12-cationic lipid that incorporates a lysine-derived moiety (LYCl) is combined with a fusogenic helper lipid (DOPE) and evaluated as a potential vehicle to transfect two plasmid DNAs (encoding GFP and luciferase) into COS-7 cells. A multidisciplinary approach (that includes potential, gel electrophoresis, SAXS, cryo-TEM, FACS, luminometry and cytotoxicity experiments, and an MM and MD computational study) indicates that LYCl/DOPE nanocarriers are stable and capable of compacting and protecting both pDNAs against DNase I degradation. The lipid formulations with 20% of LYCl content are able to complete the transfection process efficiently and cell-safely, improving the outcomes of the control Lipo2000*. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (70)

  • Article
  • Open Access
13 Citations
3,971 Views
16 Pages

Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model

  • Dave Lumen,
  • Simo Näkki,
  • Surachet Imlimthan,
  • Elisavet Lambidis,
  • Mirkka Sarparanta,
  • Wujun Xu,
  • Vesa-Pekka Lehto and
  • Anu J. Airaksinen

Polyethylene glycol (PEG) has been successfully used for improving circulation time of several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi NPs) has remained challenging. Here, we report a site specific radiolabel...

  • Article
  • Open Access
57 Citations
9,172 Views
25 Pages

An Inhalable Theranostic System for Local Tuberculosis Treatment Containing an Isoniazid Loaded Metal Organic Framework Fe-MIL-101-NH2—From Raw MOF to Drug Delivery System

  • Gabriela Wyszogrodzka-Gaweł,
  • Przemysław Dorożyński,
  • Stefano Giovagnoli,
  • Weronika Strzempek,
  • Edyta Pesta,
  • Władysław P. Węglarz,
  • Barbara Gil,
  • Elżbieta Menaszek and
  • Piotr Kulinowski

The theranostic approach to local tuberculosis treatment allows drug delivery and imaging of the lungs for a better control and personalization of antibiotic therapy. Metal-organic framework (MOF) Fe-MIL-101-NH2 nanoparticles were loaded with isoniaz...

  • Article
  • Open Access
52 Citations
8,626 Views
22 Pages

Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach

  • Do-Hoon Kuk,
  • Eun-Sol Ha,
  • Dong-Hyun Ha,
  • Woo-Yong Sim,
  • Seon-Kwang Lee,
  • Ji-Su Jeong,
  • Jeong-Soo Kim,
  • In-hwan Baek,
  • Heejun Park and
  • Du Hyung Choi
  • + 4 authors

The purpose of this study was to develop a resveratrol nanosuspension with enhanced oral bioavailability, based on an understanding of the formulation and process parameters of nanosuspensions and using a quality by design (QbD) approach. Particularl...

  • Correction
  • Open Access
4 Citations
2,918 Views
2 Pages

The appropriate information for the reprint used with permission from [...]

  • Review
  • Open Access
22 Citations
6,030 Views
16 Pages

Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer

  • Ana Paula Dinis Ano Bom,
  • Patrícia Cristina da Costa Neves,
  • Carlos Eduardo Bonacossa de Almeida,
  • Dilson Silva and
  • Sotiris Missailidis

Both aptamers and siRNA technologies have now reached maturity, and both have been validated with a product in the market. However, although pegaptanib reached the market some time ago, there has been a slow process for new aptamers to follow. Today,...

  • Article
  • Open Access
48 Citations
4,931 Views
16 Pages

Itraconazole (ITR) is a broad-spectrum antifungal drug, which has been shown to possess some promising anticancer, anti-proliferative, and anti-angiogenic properties in some cancers, such as cancers of the lung, breast, and skin. However, ITR has som...

  • Article
  • Open Access
26 Citations
4,880 Views
18 Pages

Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection

  • Andrés González,
  • Javier Casado,
  • Eduardo Chueca,
  • Sandra Salillas,
  • Adrián Velázquez-Campoy,
  • Vladimir Espinosa Angarica,
  • Lucie Bénejat,
  • Jérome Guignard,
  • Alban Giese and
  • Javier Sancho
  • + 2 authors

Antibiotic resistance is a major cause of the increasing failures in the current eradication therapies against Helicobacter pylori. In this scenario, repurposing drugs could be a valuable strategy to fast-track novel antimicrobial agents. In the pres...

  • Article
  • Open Access
28 Citations
4,659 Views
22 Pages

Development and Percutaneous Permeation Study of Escinosomes, Escin-Based Nanovesicles Loaded with Berberine Chloride

  • Giulia Vanti,
  • Daniele Bani,
  • Maria Cristina Salvatici,
  • Maria Camilla Bergonzi and
  • Anna Rita Bilia

Escin is a natural saponin, clinically used for the anti-edematous and anti-inflammatory effects. The aim of the study was to explore the possibility of converting escin into vesicle bilayer-forming component. The hyaluronidase inhibition activity of...

  • Article
  • Open Access
18 Citations
4,090 Views
20 Pages

In this study, we prepared gold nanostar (GNS) composite nanoparticles containing siRNA of cyclooxygenase-2(siCOX-2) that were modified by tumor targeting ligand 2-deoxyglucose (DG) and transmembrane peptide 9-poly-D-arginine (9R) to form siCOX-2(9R/...

  • Article
  • Open Access
46 Citations
5,752 Views
18 Pages

Design and Optimization of Nanostructured Lipid Carrier Containing Dexamethasone for Ophthalmic Use

  • Eszter L. Kiss,
  • Szilvia Berkó,
  • Attila Gácsi,
  • Anita Kovács,
  • Gábor Katona,
  • Judit Soós,
  • Erzsébet Csányi,
  • Ilona Gróf,
  • András Harazin and
  • Mária A. Deli
  • + 1 author

The aim of this study was to perform a preformulation study of dexamethasone (DXM)-loaded nanostructured lipid carriers (NLCs) for ocular use. Lipid screening was applied to find the most suitable solid and liquid lipids and surfactant for the NLC fo...

of 7

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923